Raymond F. Palmer

Last updated
Raymond Francis Palmer
Alma mater University of Southern California
Scientific career
Fields Family medicine, child psychiatry
Institutions University of Texas Health Science Center at San Antonio
Thesis Cardiovascular reactivity as a moderator of the relation between cynical hostility and serum lipids : are there genetic influences?  (1995)

Raymond F. Palmer is an associate professor of family and community medicine at the University of Texas Health Science Center at San Antonio (UTHSCSA), a post he has held since 2003. [1] His area of expertise is biostatistics. [2]

In one study, Palmer et al. correlated Environmental Protection Agency data about the release of mercury in 254 Texas counties with special education cases and autism diagnoses in the state's 1,200 school districts. [3] [4] At a press conference, Palmer stated that "This is not a definitive study, but just one more that furthers the association between environmental mercury and autism." [5] Thomas Lewandowski stated in a viewpoint that "... the conclusions drawn from the analysis are questionable", [6] and Palmer told WebMD that this type of study is not necessarily proof of a causative link between mercury and autism. [7]

Palmer has studied baby teeth for environmental toxins the children could have been exposed to during the prenatal period; this research was funded by a Suzanne and Bob Wright Trailblazer grant from Autism Speaks. [8] He has also studied the differences in autism rates between Hispanic children and white children, and has concluded that the former are less likely to be diagnosed with the disorder than the latter. He says that this difference is unlikely to be solely an artifact of socioeconomic factors. [9] [10]

Education

Palmer has a bachelor's degree in psychology from Long Beach State University (1980), as well as an M.A. in psychology from California State University, Dominguez Hills (1985) and a PhD in preventive medicine from the University of Southern California (1995). [2]

Related Research Articles

<span class="mw-page-title-main">Asperger syndrome</span> Former neurodevelopmental diagnosis

Asperger syndrome (AS), also known as Asperger's, is a neurodevelopmental condition characterized by significant difficulties in social interaction and nonverbal communication, along with restricted and repetitive patterns of behaviour and interests. The syndrome is no longer recognised as a diagnosis in itself, having been merged with other conditions into autism spectrum disorder (ASD). It was considered to differ from other diagnoses that were merged into ASD by relatively unimpaired spoken language and intelligence.

<span class="mw-page-title-main">Chelation therapy</span> Medical procedure to remove heavy metals from the body

Chelation therapy is a medical procedure that involves the administration of chelating agents to remove heavy metals from the body. Chelation therapy has a long history of use in clinical toxicology and remains in use for some very specific medical treatments, although it is administered under very careful medical supervision due to various inherent risks, including the mobilization of mercury and other metals through the brain and other parts of the body by the use of weak chelating agents that unbind with metals before elimination, exacerbating existing damage. To avoid mobilization, some practitioners of chelation use strong chelators, such as selenium, taken at low doses over a long period of time.

<span class="mw-page-title-main">Controversies in autism</span> Controversies about both the cause of autism and the nature of the diagnoses themselves

Diagnoses of autism have become more frequent since the 1980s, which has led to various controversies about both the cause of autism and the nature of the diagnoses themselves. Whether autism has mainly a genetic or developmental cause, and the degree of coincidence between autism and intellectual disability, are all matters of current scientific controversy as well as inquiry. There is also more sociopolitical debate as to whether autism should be considered a disability on its own.

Generation Rescue is a nonprofit organization that advocates the scientifically disproven view that autism and related disorders are primarily caused by environmental factors, particularly vaccines. The organization was established in 2005 by Lisa and J.B. Handley. Today, Generation Rescue is known as a platform for Jenny McCarthy's autism related anti-vaccine advocacy.

<span class="mw-page-title-main">Heritability of autism</span>

The heritability of autism is the proportion of differences in expression of autism that can be explained by genetic variation; if the heritability of a condition is high, then the condition is considered to be primarily genetic. Autism has a strong genetic basis, although the genetics of autism are complex and it is unclear whether autism spectrum disorder (ASD) is explained more by multigene interactions or by rare mutations with major effects.

Thiomersal is a mercury compound which is used as a preservative in some vaccines. Anti-vaccination activists promoting the incorrect claim that vaccination causes autism have asserted that the mercury in thiomersal is the cause. There is no scientific evidence to support this claim. The idea that thiomersal in vaccines might have detrimental effects originated with anti-vaccination activists and was sustained by them and especially through the action of plaintiffs' lawyers.

<span class="mw-page-title-main">Causes of autism</span> Proposed causes of autism

Many causes of autism have been proposed, but understanding of the theory of causation of autism, or otherwise known as autism spectrum disorder (ASD) is incomplete. Attempts have been made to incorporate the known genetic and environmental causes into a comprehensive causative framework. ASD is a complex developmental condition marked by persistent challenges to social interaction, speech and nonverbal communication, and restricted/repetitive behaviors and its phenotypes vary significantly.

The epidemiology of autism is the study of the incidence and distribution of autism spectrum disorders (ASD). A 2022 systematic review of global prevalence of autism spectrum disorders found a median prevalence of 1% in children in studies published from 2012 to 2021, with a trend of increasing prevalence over time. However, the study’s 1% figure may reflect an underestimate of prevalence in low- and middle-income countries.

<span class="mw-page-title-main">Mady Hornig</span> American psychiatrist

Mady Hornig is an American psychiatrist and an associate professor of epidemiology at Columbia University's Mailman School of Public Health. A physician-scientist, her research involves clinical, epidemiological, and animal model research on autism and related neurodevelopmental conditions. She directs the clinical core of an international investigation of the role of Borna disease virus in human mental illness and participates as a key investigator for the Autism Birth Cohort (ABC) project, a large prospective epidemiological study, based in Norway, that is identifying how genes and timing interact with environmental agents preceding the onset of autism spectrum diagnoses. In 2006, she was appointed as Guest Professor at the School of Basic Medical Science of Beijing University in Beijing, China.

Laura Charlotte Hewitson is a British-born primate researcher noted for her work in the fields of reproductive biology and behavior. She is an affiliate scientist at the Washington National Primate Research Center (WaNPRC) and adjunct associate professor of psychiatry at the University of Texas Southwestern Medical Center. Additionally, she is Research Director of The Johnson Center for Child Health and Development in Austin, Texas. Hewitson was a staff scientist at Oregon Health Sciences University from 1997 to 2001. From 2002 to 2010 she was an associate professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine and member of Magee-Women's Research Institute and Foundation (MWRI&F) in Pittsburgh, Pennsylvania.

<span class="mw-page-title-main">Autism spectrum</span> Medical condition

The autism spectrum, often referred to as just autism, autism spectrum disorder (ASD) or sometimes autism spectrum condition (ASC), identifies a loosely defined cluster of neurodevelopmental issues characterized by challenges in social interaction, verbal and nonverbal communication, and often repetitive behaviors and restricted interests. Other common features include unusual responses to sensory stimuli and a preference for sameness or unusual adherence to routines.

Claudia S. Miller, an allergist and immunologist, is an author, instructor, and scientist noted for research in chemical intolerance, and development of tools for its diagnosis. Miller is a professor of occupational and environmental medicine in the School of Medicine at the University of Texas Health Science Center at San Antonio. She also is assistant dean for the school's M.D.-M.P.H. program, and vice chair of community medicine in the school's Department of Family and Community Medicine.

<i>Cedillo v. Secretary of Health and Human Services</i> Legal case in United States Court of Federal Claims, decided February 12, 2009

Michelle Cedillo v. Secretary of Health and Human Services, also known as Cedillo, was a court case involving the family of Michelle Cedillo, an autistic girl whose parents sued the United States government because they believed that her autism was caused by her receipt of both the measles-mumps-and-rubella vaccine and thimerosal-containing vaccines. The case was a part of the Omnibus Autism Proceeding, where petitioners were required to present three test cases for each proposed mechanism by which vaccines had, according to them, caused their children's autism; Cedillo was the first such case for the MMR-and-thimerosal hypothesis.

<span class="mw-page-title-main">Jeffrey Brent</span> Medical toxicologist

Jeffrey A. Brent is a medical toxicologist who is a distinguished clinical professor of medicine and emergency medicine at the University of Colorado, School of Medicine. In addition, he is a professor at the Department of Environmental and Occupational Health at the Colorado School of Public Health. He is also the past president of the American Academy of Clinical Toxicology, was editor in chief of the journal Toxicological Reviews, and was a member of the board of directors of the American College of Medical Toxicology. Previously, most of Brent's research focused on the use of fomepizole as a treatment for both methanol and ethylene glycol poisoning, and he led a trial of this drug which resulted in the FDA approving it in December 1997. Currently, Brent serves as Director of the Toxicology Investigators Consortium, an NIH and FDA supported multi center research and surveillance group. Brent is also a senior editor of "Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient," originally published in 2005, and now in its second edition, which was published in 2017.

Hurair Vasken Aposhian was a Ph.D. toxicologist and an emeritus professor of molecular and cell biology at the University of Arizona, a post he held beginning in 1975. He is also a former professor of pharmacology at the medical school at said university. He received his bachelor's degree in chemistry, at Brown University, 1948. He received a master's degree and a PhD in physiological chemistry at the University of Rochester, where he published some scientific studies about the synthesis of isoalloxazine ring-containing compounds. He did a postdoctoral with Nobel Laureate Arthur Kornberg in the department of biochemistry at Stanford University School of Medicine. He has done sabbatical scholar-in-residence at MIT and at the University of California at San Diego. He is best known for his pioneering work on Succimer and Unithiol in the treatment of arsenic, mercury, lead and other heavy metals leading to FDA approval of succimer in childhood lead poisoning at levels over 40 ug/dl. Previous posts he had held include at Vanderbilt, Tufts University, and the University of Maryland. His views about mercury in vaccines and in dental amalgams go against the consensus of the medical community and are controversial.

Richard Eugene Frye is an American autism researcher and associate professor at Arizona Children's Hospital in Phoenix, and formerly of the University of Arkansas for Medical Sciences's department of pediatrics, as well as the Director of the Autism Multispecialty Clinic at Arkansas Children’s Hospital. Frye was formerly a faculty member at the University of Texas Health Science Center at Houston's division of child and adolescent neurology.

The development of an animal model of autism is one approach researchers use to study potential causes of autism. Given the complexity of autism and its etiology, researchers often focus only on single features of autism when using animal models.

The CHARGE study, which stands for Childhood Autism Risks from Genetics and the Environment, was launched in 2003 by researchers at the MIND Institute. It describes its goal as to research the role of gene-environment interactions in influencing autism risk. Scientists involved in the research include Irva Hertz-Picciotto, who is the study's principal investigator. The study is funded by the National Institutes of Health. Over 1,000 families have participated in the study. The children in the study are divided into three groups: children with autism, children with developmental delay, and children chosen at random from the general population.

This article summarizes healthcare in Texas. In 2017, the United Healthcare Foundation ranked Texas as the 34th healthiest state in the United States. Obesity, excessive drinking, maternal mortality, infant mortality, and vaccinations are among the major public health issues facing Texas.

Men and boys are more frequently diagnosed with autism than women and girls. It is debated whether this is due to a sex difference in rates of autism spectrum disorders (ASD) or whether females are underdiagnosed. The prevalence ratio is often cited as about 4 males for every 1 female diagnosed. Other research indicates that it closer to 3:1 or 2:1. One in every 42 males and one in 189 females in the United States is diagnosed with autism spectrum disorder. There is some evidence that females may also receive diagnoses somewhat later than males; however, thus far results have been contradictory.

References

  1. "Raymond Palmer, PhD". University of Texas Health Science Center at San Antonio. Retrieved 13 November 2013.
  2. 1 2 "Raymond F. Palmer". University of Texas Health Science Center at San Antonio. Archived from the original on 24 February 2010. Retrieved 2 November 2013.
  3. Maugh, Thomas H. (17 March 2005). "Possible Mercury, Autism Connection Found in Study". Los Angeles Times . Retrieved 2 November 2013.
  4. Palmer, R. F.; Blanchard, S.; Stein, Z.; Mandell, D.; Miller, C. (2006). "Environmental mercury release, special education rates, and autism disorder: An ecological study of Texas". Health & Place. 12 (2): 203–9. doi:10.1016/j.healthplace.2004.11.005. PMID   16338635.
  5. "Autism Risk Linked To Distance From Power Plants, Other Mercury-Releasing Sources". Science Daily . 25 April 2008. Retrieved 2 November 2013.
  6. Lewandowski, T. A. (2006). "Questions regarding environmental mercury release, special education rates, and autism disorder: An ecological study of Texas by Palmer et al". Health & Place. 12 (4): 749–750. doi:10.1016/j.healthplace.2005.10.005. PMID   16337825.
  7. Denoon, Daniel J. (18 March 2005). "Mercury in Air Pollution: A Link to Autism?". WebMD . Retrieved 2 November 2013.
  8. "What's New in Environmental Research?". Autism Speaks official blog. 13 July 2012. Retrieved 2 November 2013.
  9. "Texas study confirms lower autism rate in Hispanics". Reuters . 29 December 2009. Retrieved 4 November 2013.
  10. Palmer, R. F.; Walker, T.; Mandell, D.; Bayles, B.; Miller, C. S. (2010). "Explaining Low Rates of Autism Among Hispanic Schoolchildren in Texas". American Journal of Public Health. 100 (2): 270–272. doi:10.2105/AJPH.2008.150565. PMC   2804636 . PMID   20019320.